RESUMO
Evidence implicates ARTD1 in cell differentiation, but its role in skeletal metabolism remains unknown. Osteoclasts (OC), the bone-resorbing cells, differentiate from macrophages under the influence of macrophage colony-stimulating factor (M-CSF) and receptor-activator of NF-κB ligand (RANKL). We found that M-CSF induced ADP-ribosyltransferase diphtheria toxin-like 1 (ARTD1) auto-ADP-ribosylation in macrophages, a modification that marked ARTD1 for cleavage, and subsequently, for degradation upon RANKL exposure. We established that ARTD1 proteolysis was NLRP3 inflammasome-dependent, and occurred via the proteasome pathway. Since ARTD1 is cleaved at aspartate(214), we studied the impact of ARTD1 rendered uncleavable by D214N substitution (ARTD1(D214N)) on skeletal homeostasis. ARTD1(D214N), unlike wild-type ARTD1, was resistant to cleavage and degradation during osteoclastogenesis. As a result, ARTD1(D214N) altered histone modification and promoted the abundance of the repressors of osteoclastogenesis by interfering with the expression of B lymphocyte-induced maturation protein 1 (Blimp1), the master regulator of anti-osteoclastogenic transcription factors. Importantly, ARTD1(D214N)-expressing mice exhibited higher bone mass compared with controls, owing to decreased osteoclastogenesis while bone formation was unaffected. Thus, unless it is degraded, ARTD1 represses OC development through transcriptional regulation.
Assuntos
Proteínas de Transporte/metabolismo , Inflamassomos/metabolismo , Osteoclastos/metabolismo , Poli(ADP-Ribose) Polimerases/metabolismo , Proteólise , Transcrição Gênica , Substituição de Aminoácidos , Animais , Proteínas de Transporte/genética , Histonas/genética , Histonas/metabolismo , Inflamassomos/genética , Camundongos , Camundongos Knockout , Mutação de Sentido Incorreto , Proteína 3 que Contém Domínio de Pirina da Família NLR , Osteoclastos/citologia , Poli(ADP-Ribose) Polimerase-1 , Poli(ADP-Ribose) Polimerases/genética , Processamento de Proteína Pós-Traducional/genéticaRESUMO
Primary cells respond to irradiation by activation of the DNA damage response and cell cycle arrest, which eventually leads to senescence or apoptosis. It is not clear in detail which signaling pathways or networks regulate the induction of either apoptosis or senescence. Primary human fibroblasts are able to withstand high doses of irradiation and to prevent irradiation-induced apoptosis. However, the underlying regulatory basis for this phenotype is not well understood. Here, a kinetic network analysis based on reverse phase protein arrays (RPPAs) in combination with extensive western blot and cell culture analyses was employed to decipher the cytoplasmic and nuclear signaling networks and to identify possible antiapoptotic pathways. This analysis identified activation of known DNA damage response pathways (e.g., phosphorylation of MKK3/6, p38, MK2, Hsp27, p53 and Chk1) as well as of prosurvival (e.g., MEK-ERK, cAMP response element-binding protein (CREB), protein kinase C (PKC)) and antiapoptotic markers (e.g., Bad, Bcl-2). Interestingly, PKC family members were activated early upon irradiation, suggesting a regulatory function in the ionizing radiation (IR) response of these cells. Inhibition or downregulation of PKC in primary human fibroblasts caused IR-dependent downregulation of the identified prosurvival (CREB phosphorylation) and antiapoptotic (Bad phosphorylation, Bcl-2) markers and thus lead to a proliferation stop and to apoptosis. Taken together, our analysis suggests that cytoplasmic PKC signaling conditions IR-stressed MRC-5 and IMR-90 cells to prevent irradiation-induced apoptosis. These findings contribute to the understanding of the cellular and nuclear IR response and may thus eventually improve the efficacy of radiotherapy and help overcome tumor radioresistance.
Assuntos
Apoptose/efeitos da radiação , Fibroblastos/citologia , Proteína Quinase C/metabolismo , Radiação Ionizante , Proteína de Ligação a CREB/metabolismo , Análise por Conglomerados , Dano ao DNA/efeitos da radiação , Reparo do DNA , Regulação para Baixo , Fibroblastos/metabolismo , Humanos , Fosforilação , Mapas de Interação de Proteínas , Proteoma/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Proteína do Retinoblastoma/metabolismo , Transdução de Sinais , Proteína de Morte Celular Associada a bcl/metabolismoRESUMO
Mammalian poly(ADP-ribose)polymerase 1 (PARP-1) is an abundant nuclear chromatin-associated protein and belongs to a large family of enzymes that catalyzes the transfer of ADP-ribose units from its substrate beta-nicotinamide adenine dinucleotide (NAD+) covalently to itself and other nuclear chromatin-associated proteins. PARP-1 knockout mice are protected against myocardial infarction, streptozotocin-induced diabetes, lipopolysaccharide-induced septic shock, and zymosan-induced multiple organ failure, indicating that PARP-1 is involved in the regulation of the pathogenesis of these disorders. PARP-1 and nuclear factor kappa B (NF-kappaB) have both been suggested to play a crucial role in inflammatory disorders. NF-kappaB encompasses a family of inducible transcription factors which play a crucial role in the regulation of genes involved in immune and inflammatory responses. Recent reports have shown that PARP-1 can act as a coactivator of NF-kappaB. These findings might provide new insights into the pathophysiology of different diseases such as type I diabetes and septic shock. The purpose of this review is to give a short overview of the current knowledge about PARP-1 and its functional and biochemical interactions with NF-kappaB. A more precise role for PARP-1 in NF-kappaB-dependent gene regulation and cellular metabolism during development of pathophysiological processes is discussed. Special considerations is given to the pathophysiological significance of these findings in terms of inflammatory disorders.
Assuntos
Inflamação/metabolismo , NF-kappa B/fisiologia , Poli(ADP-Ribose) Polimerases/fisiologia , Animais , Diabetes Mellitus Tipo 1/metabolismo , Homeostase , Humanos , Inflamação/imunologia , Camundongos , Camundongos Knockout , Insuficiência de Múltiplos Órgãos/metabolismo , NF-kappa B/genética , Necrose , Neoplasias/metabolismo , Poli(ADP-Ribose) Polimerases/genética , Choque Séptico/metabolismo , Distribuição TecidualRESUMO
Poly(ADP-ribose) polymerase 1 (PARP-1)-deficient mice are protected against septic shock, diabetes type I, stroke, and inflammation. We report that primary cells from PARP-1(-/-) animals are impaired in kappa B-dependent transcriptional activation induced by different stimuli involved in inflammatory and genotoxic stress signaling. PARP-1 was also required for p65-mediated transcriptional activation. PARP-1 enzymatic inhibitors did not inhibit the transcriptional activation of a kappa B-dependent reporter gene in wild type cells. Remarkably, neither the enzymatic activity nor the DNA binding activity of PARP-1 was required for kappa B-dependent transcriptional activation in PARP-1(-/-) cells complemented with different PARP-1 mutants. However, PARP-1 interacted in vitro directly with both subunits of NF-kappa B (p50 and p65), and mapping of the interaction domains revealed that both subunits bind to different PARP-1 domains. Furthermore, a PARP-1 mutant lacking the enzymatic and DNA binding activity interacted comparably to the wild type PARP-1 with p65 or p50. Finally, we showed that PARP-1 is activating the natural inducible nitric-oxide synthase and P-selectin promoter in a kappa B-dependent manner upon stimulation of the cells with inflammatory stimuli or cotransfection of p65. Our results provide evidence that neither the DNA binding nor the enzymatic activity of PARP-1 but its direct protein-protein interaction with both subunits of NF-kappa B is required for its coactivator function, thus expanding the role of PARP-1 as an essential and novel classical transcriptional coactivator for kappa B-dependent gene expression in vivo.
Assuntos
NF-kappa B/metabolismo , Poli(ADP-Ribose) Polimerases/metabolismo , Linfócitos B/metabolismo , Sequência de Bases , Sítios de Ligação , Linhagem Celular , Primers do DNA , Ativação Enzimática , Humanos , Mediadores da Inflamação/farmacologia , Mutagênicos/farmacologia , Óxido Nítrico Sintase/metabolismo , Óxido Nítrico Sintase Tipo II , Selectina-P/genética , Inibidores de Poli(ADP-Ribose) Polimerases , Regiões Promotoras Genéticas , Ligação Proteica , Linfócitos T/metabolismo , Transcrição GênicaRESUMO
Ordered molecular interactions and structural changes must take place within the human immunodeficiency virus type 1 (HIV-1) preintegration complex at various stages for successful viral replication. We demonstrate both physical and biochemical interactions between HIV-1 reverse transcriptase and integrase enzymes. This interaction may have implications on the in vivo functions of the two enzymes within the HIV-1 replication complex. It may be one of the various molecular interactions, which facilitate efficient HIV-1 replication within the target cells.
Assuntos
Integrase de HIV/metabolismo , Transcriptase Reversa do HIV/metabolismo , HIV-1/enzimologia , Sequência de Bases , DNA Viral/genética , DNA Viral/metabolismo , Integrase de HIV/química , Inibidores de Integrase de HIV/metabolismo , Repetição Terminal Longa de HIV , Transcriptase Reversa do HIV/química , HIV-1/genética , HIV-1/fisiologia , Humanos , Inibidores da Transcriptase Reversa/metabolismo , Replicação Viral/fisiologiaRESUMO
Identification and characterization of protein-protein interactions between the host cell and parasites both enhance our understanding of basic cell biology and provide insights into central processes of parasite life cycles. Research on HIV-1 has broadened our knowledge of the various molecular events involved. However, our understanding of how this virus interacts with the host cell at the level of protein-protein interaction is still limited. Through these interactions the virus is able to recruit certain cellular metabolic pathways for its replication. Here we summarize our current knowledge of protein-protein interactions between HIV-1 and host cell factors during viral replication.
Assuntos
HIV-1/genética , Proteínas Virais/genética , Replicação Viral/genética , Regulação Viral da Expressão Gênica , Genômica , Infecções por HIV/virologia , HIV-1/química , HIV-1/crescimento & desenvolvimento , Humanos , Transcrição Gênica/genética , Proteínas Virais/fisiologiaRESUMO
We describe a role for the transcriptional coactivator p300 in DNA metabolism. p300 formed a complex with flap endonuclease-1 (Fen1) and acetylated Fen1 in vitro. Furthermore, Fen1 acetylation was observed in vivo and was enhanced upon UV treatment of human cells. Remarkably, acetylation of the Fen1 C terminus by p300 significantly reduced Fen1's DNA binding and nuclease activity. Proliferating cell nuclear antigen (PCNA) was able to stimulate both acetylated and unacetylated Fen1 activity to the same extent. Our results identify acetylation as a novel regulatory modification of Fen1 and implicate that p300 is not only a component of the chromatin remodeling machinery but might also play a critical role in regulating DNA metabolic events.
Assuntos
Endodesoxirribonucleases/genética , Endodesoxirribonucleases/metabolismo , Proteínas Nucleares/genética , Proteínas Nucleares/metabolismo , Transativadores/genética , Transativadores/metabolismo , Ativação Transcricional/fisiologia , Acetilação/efeitos da radiação , Sequência de Aminoácidos , Sítios de Ligação , Cromatina/metabolismo , DNA/metabolismo , Endodesoxirribonucleases/química , Endonucleases Flap , Células HeLa , Humanos , Técnicas In Vitro , Lisina/metabolismo , Dados de Sequência Molecular , Proteínas Nucleares/química , Antígeno Nuclear de Célula em Proliferação/metabolismo , Estrutura Terciária de Proteína , Transativadores/química , Raios UltravioletaRESUMO
The transcriptional coactivator p300 interacts with many transcription factors that participate in a broad spectrum of biological activities, such as cellular differentiation, homeostasis and growth control. Mouse embryos lacking both p300 alleles die around mid-gestation, with pleiotropic defects in morphogenesis, in cell differentiation and, unexpectedly, in cell proliferation because of reduced DNA synthesis. Here we show that p300 may have a role in DNA repair synthesis through its interaction with proliferating cell nuclear antigen (PCNA). We show that in vitro and in vivo p300 forms a complex with PCNA that does not depend on the S phase of cell cycle. A large fraction of both p300 and PCNA colocalize to speckled structures in the nucleus. Furthermore, the endogenous p300-PCNA complex stimulates DNA synthesis in vitro. Chromatin immunoprecipitation experiments indicate that p300 is associated with freshly synthesized DNA after ultraviolet irradiation. Our results suggest that p300 may participate in chromatin remodelling at DNA lesion sites to facilitate PCNA function in DNA repair synthesis.
Assuntos
Reparo do DNA , DNA/biossíntese , Proteínas Nucleares/metabolismo , Antígeno Nuclear de Célula em Proliferação/metabolismo , Transativadores/metabolismo , Animais , Sítios de Ligação , Ciclo Celular , Cromatina/metabolismo , Proteína p300 Associada a E1A , Células HeLa , Humanos , Camundongos , Mutação , Testes de Precipitina , Antígeno Nuclear de Célula em Proliferação/genética , Ligação Proteica , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/metabolismoRESUMO
Productive viral infection requires coordinate regulation of viral and cellular gene expression. Viruses of different classes have evolved different mechanisms to conform to, adapt to and exploit programs of cellular gene expression. Many viral gene products influence and respond to cellular signals that control differentiation and proliferation Transcriptional coactivators are central to the regulation of the expression of genes controlling these events. p300 and CBP are closely related coactivators that regulate the transcription of specific genes, modify chromatin structure and influence cell cycle progression. In this review, the different molecular interactions of proteins encoded by DNA tumor viruses and lentiviruses with these transcriptional coactivators and related cellular proteins are summarized.
Assuntos
Vírus de DNA Tumorais/fisiologia , Lentivirus/fisiologia , Transativadores/metabolismo , Replicação Viral/fisiologia , Animais , Proteína de Ligação a CREB , Transformação Celular Viral , Vírus de DNA Tumorais/genética , Regulação Viral da Expressão Gênica , Histona Acetiltransferases , Humanos , Lentivirus/genética , Camundongos , Proteínas Nucleares/metabolismo , Coativador 3 de Receptor NuclearRESUMO
The beta-catenin protein plays a critical role in embryonic development and mature tissue homeostasis through its effects on E-cadherin-mediated cell adhesion and Wnt-dependent signal transduction. In colon and other cancers, mutations of beta-catenin or the adenomatous polyposis coli (APC) tumor suppressor appear to stabilize beta-catenin and enhance its interaction with T cell factor (TCF) or lymphoid enhancer factor (Lef) transcription factors. At present, a complete picture of the means by which beta-catenin's interactions with TCF/Lef proteins contribute to neoplastic transformation is lacking. We report that the transcriptional coactivator p300 interacts with beta-catenin in vitro and in vivo and is critical for beta-catenin-mediated neoplastic transformation. p300 synergistically activates beta-catenin/TCF transcription, and their biochemical association requires the CH1 domain of p300 and a region of beta-catenin that includes its NH(2)-terminal transactivation domain and the first two armadillo repeats. Lowering of cellular p300 levels by using a ribozyme directed against p300 reduced TCF transcriptional activity and inhibited the neoplastic growth properties of a beta-catenin-transformed rat epithelial cell line and a human colon carcinoma line with a beta-catenin mutation. These findings demonstrate a critical role for p300 in beta-catenin/TCF transcription and in cancers arising from defects in beta-catenin regulation.
Assuntos
Transformação Celular Neoplásica , Proteínas do Citoesqueleto/metabolismo , Proteínas de Ligação a DNA/genética , Proteínas Nucleares/metabolismo , Transativadores/metabolismo , Fatores de Transcrição/genética , Animais , Linhagem Celular , Proteínas do Citoesqueleto/genética , Proteína p300 Associada a E1A , Regulação da Expressão Gênica , Humanos , Células Jurkat , Fator 1 de Ligação ao Facilitador Linfoide , Camundongos , Proteínas Nucleares/genética , Proteínas Nucleares/fisiologia , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/metabolismo , Proteínas Recombinantes de Fusão/fisiologia , Transativadores/genética , Transativadores/fisiologia , Transcrição Gênica , Células Tumorais Cultivadas , beta CateninaRESUMO
Proliferating cell nuclear antigen is best known as a DNA polymerase accessory protein but has more recently also been shown to have different functions in important cellular processes such as DNA replication, DNA repair, and cell cycle control. PCNA has been found in quaternary complexes with the cyclin kinase inhibitor p21 and several pairs of cyclin-dependent protein kinases and their regulatory partner, the cyclins. Here we show a direct interaction between PCNA and Cdk2. This interaction involves the regions of the PCNA trimer close to the C termini. We found that PCNA and Cdk2 form a complex together with cyclin A. This ternary PCNA-Cdk2-cyclin A complex was able to phosphorylate the PCNA binding region of the large subunit of replication factor C as well as DNA ligase I. Furthermore, PCNA appears to be a connector between Cdk2 and DNA ligase I and to stimulate phosphorylation of DNA ligase I. Based on our results, we propose the model that PCNA brings Cdk2 to proteins involved in DNA replication and possibly might act as an "adaptor" for Cdk2-cyclin A to PCNA-binding DNA replication proteins.
Assuntos
Quinases relacionadas a CDC2 e CDC28 , Quinases Ciclina-Dependentes/metabolismo , Antígeno Nuclear de Célula em Proliferação/metabolismo , Proteínas Serina-Treonina Quinases/metabolismo , Linhagem Celular , Núcleo Celular/metabolismo , Ciclina A/metabolismo , Quinase 2 Dependente de Ciclina , DNA Ligase Dependente de ATP , DNA Ligases/metabolismo , Replicação do DNA , Humanos , Fosforilação , Ligação Proteica , Ressonância de Plasmônio de SuperfícieRESUMO
The transcription factor NF-kappaB plays a critical role in immune and inflammatory responses. Here we show that poly (ADP ribose) polymerase (PARP) is required for specific NF-kappaB transcriptional activation in vivo. The activation of the HIV-LTR promoter and an NF-kappaB-dependent artificial promoter was drastically reduced in PARP (-/-) cells, independently of the signaling pathway through which NF-kappaB was induced. Furthermore NF-kappaB-dependent gene activation was restored in vivo by the expression of PARP in PARP (-/-) cells. Finally, we show that both NF-kappaB and PARP formed a stable immunoprecipitable nuclear complex. This interaction did not need DNA binding. Our results suggest that PARP is an important cofactor in the activation cascade of NF-kappaB-dependent target genes.
Assuntos
NF-kappa B/metabolismo , Poli(ADP-Ribose) Polimerases/metabolismo , Ativação Transcricional , Células Cultivadas , DNA/metabolismo , Proteínas de Ligação a DNA/metabolismo , Humanos , NF-kappa B/biossíntese , Ligação Proteica , Transdução de SinaisRESUMO
We have identified and characterized CIPER, a novel protein containing a caspase recruitment domain (CARD) in its N terminus and a C-terminal region rich in serine and threonine residues. The CARD of CIPER showed striking similarity to E10, a product of the equine herpesvirus-2. CIPER formed homodimers via its CARD and interacted with viral E10 but not with several apoptosis regulators containing CARDs including ARC, RAIDD, RICK, caspase-2, caspase-9, or Apaf-1. Expression of CIPER induced NF-kappaB activation, which was inhibited by dominant-negative NIK and a nonphosphorylable IkappaB-alpha mutant but not by dominant-negative RIP. Mutational analysis revealed that the N-terminal region of CIPER containing the CARD was sufficient and necessary for NF-kappaB-inducing activity. Point mutations in highly conserved residues in the CARD of CIPER disrupted the ability of CIPER to activate NF-kappaB and to form homodimers, indicating that the CARD is essential for NF-kappaB activation and dimerization. We propose that CIPER acts in a NIK-dependent pathway of NF-kappaB activation.
Assuntos
Proteínas Adaptadoras de Transdução de Sinal , Apoptose , Caspases/metabolismo , NF-kappa B/metabolismo , Proteínas de Neoplasias/genética , Homologia de Sequência de Aminoácidos , Sequência de Aminoácidos , Animais , Fator Apoptótico 1 Ativador de Proteases , Proteína 10 de Linfoma CCL de Células B , Northern Blotting , Proteínas de Caenorhabditis elegans , Proteínas de Transporte/química , Proteínas de Transporte/metabolismo , Caspase 2 , Caspase 9 , Caspases/química , Cisteína Endopeptidases/química , Ativação Enzimática , Etiquetas de Sequências Expressas , Humanos , Células Jurkat , Camundongos , Dados de Sequência Molecular , Proteínas de Neoplasias/química , Proteínas de Neoplasias/fisiologia , Mutação Puntual , Proteínas/químicaRESUMO
Kaposi's sarcoma-associated herpesvirus (KSHV), or human herpesvirus 8, has been implicated in the development of Kaposi's sarcoma (KS) and several B-cell lymphoproliferative diseases. Most cells in lesions derived from these malignancies are latently infected, and different viral gene products have been identified in association with lytic or latent infection by KSHV. The latency-associated nuclear antigen (LANA), encoded by open reading frame 73 of the KSHV genome, is a highly immunogenic protein that is expressed predominantly during viral latency, in most KS spindle cells and in cell lines established from body-cavity-based lymphomas. Antibodies to LANA can be detected in a high percentage of HIV-infected individuals who subsequently develop KS, although its role in disease pathogenesis is not completely understood. p53 is a potent transcriptional regulator of cell growth whose induction leads either to cell-cycle arrest or apoptosis. Loss of p53 function correlates with cell transformation and oncogenesis, and several viral oncoproteins interact with p53 and modulate its biological activity. Here we show that LANA interacts with the tumour suppressor protein p53 and represses its transcriptional activity. This viral gene product further inhibits the ability of p53 to induce cell death. We propose that LANA contributes to viral persistence and oncogenesis in KS through its ability to promote cell survival by altering p53 function.
Assuntos
Apoptose , Herpesvirus Humano 8/fisiologia , Proteínas Nucleares/fisiologia , Sarcoma de Kaposi/virologia , Proteína Supressora de Tumor p53/antagonistas & inibidores , Proteínas Virais/fisiologia , Antígenos Virais , Linhagem Celular , Sobrevivência Celular , Transformação Celular Neoplásica , Transformação Celular Viral , Cloranfenicol O-Acetiltransferase/genética , Regulação Viral da Expressão Gênica , Humanos , Células Jurkat , Ligação Proteica , Transcrição Gênica , Células Tumorais CultivadasRESUMO
Direct intralesional injection of DNA encoding interferon-alpha2 (IFN-alpha2) was used in an effort to sustain local protein delivery for the treatment of human basal cell carcinoma (BCC). A novel model to study this malignancy was established by transplantation of human BCC tissue on to immunodeficient mice with a relatively high rate of engraftment and stable phenotype for superficial BCC (20 of 25; 80%). Gene transfer was significantly increased by using DNA liposome complexes (lipoplexes). Recombinant gene expression was detected predominantly in the epidermis and, to a lesser extent, in the dermis. Gene transfer of IFN-alpha2 using this method resulted in sustained production of IFN-alpha2 protein and increased expression of a known IFN-inducible gene, the class II major histocompatibility (MHC) antigen, and induced BCC regression, presumably through a non-immune mechanism. Intralesional injection of DNA lipoplexes encoding IFN-alpha protein may therefore be applicable to the treatment of cutaneous BCC.
Assuntos
Carcinoma Basocelular/terapia , Técnicas de Transferência de Genes , Terapia Genética/métodos , Interferon-alfa/genética , Neoplasias Cutâneas/terapia , Adulto , Idoso , Animais , Antígenos CD1/análise , Carcinoma Basocelular/imunologia , Feminino , Expressão Gênica , Vetores Genéticos/administração & dosagem , Antígenos HLA-DR/análise , Humanos , Imuno-Histoquímica , Injeções Intralesionais , Interferon Tipo I/uso terapêutico , Lipossomos , Masculino , Camundongos , Camundongos SCID , Pessoa de Meia-Idade , Transplante de Neoplasias , Proteínas Recombinantes , Neoplasias Cutâneas/imunologia , Resultado do TratamentoRESUMO
Human immunodeficiency virus type 1 (HIV-1) encodes the transactivator protein Tat, which is essential for viral replication and progression to disease. Here we demonstrate that transcriptional activation by HIV-1 Tat involves p300 or the related cellular transcriptional coactivator CREB binding protein (CBP). Tat transactivation was inhibited by the 12S form of the adenovirus E1A gene product, which inhibits p300 function, and this inhibition was independent of its effect on NF-kappaB transcription. A biochemical interaction of p300 with Tat was demonstrated in vitro and in vivo by coimmunoprecipitation. The carboxy-terminal region of p300, which binds to E1A, was shown to bind specifically to the highly conserved basic domain of Tat, which also mediates binding to the Tat-responsive region RNA stem-loop structure. The ability of Tat to interact physically and functionally with this coactivator provides a mechanism to assemble a basal transcription complex which may subsequently respond to the effect of Tat on transcriptional elongation and represents a novel interaction between an RNA binding protein and a transcriptional coactivator.
Assuntos
Produtos do Gene tat/metabolismo , HIV-1/metabolismo , Proteínas Nucleares/metabolismo , Transativadores/metabolismo , Proteína de Ligação a CREB , Cloranfenicol O-Acetiltransferase/genética , Humanos , Células Jurkat , Ligação Proteica , Produtos do Gene tat do Vírus da Imunodeficiência HumanaRESUMO
The host response to viral infection involves the secretion of multiple cytokines which alter immune function and viral replication. These proteins activate several signal transduction pathways in infected cells which must be integrated to regulate cellular and viral gene expression. In this report, we demonstrate that specific transcription factors induced by distinct cytokines regulate HIV transcription by competitive binding to the p300 coactivator. Interferon-alpha (IFN-alpha) was found to inhibit NF-kappaB-dependent HIV gene expression stimulated by tumor necrosis factor-alpha (TNF-alpha). This inhibition was mediated by binding of the IFN-alpha signal transducer and activator of transcription 2, Stat2, to a specific domain of p300 which also binds to the RelA (p65) subunit of NF-kappaB. p300 was found to be limiting with respect to RelA (p65) and Stat2, and this effect was reversed by overexpression of p300. Inhibition by Stat2 was specific for NF-kappaB and was not mediated by Stat1, which is also induced by IFN-alpha. Gene activation induced by the Stat2 transcription domain was also inhibited by expression of RelA. These results demonstrate that HIV transcription can be regulated in the nucleus by competitive binding of specific cytokine-induced transcription factors to a discrete domain of a transcriptional coactivator.
Assuntos
Citocinas/farmacologia , Regulação Viral da Expressão Gênica , HIV/genética , Proteínas Nucleares/metabolismo , Fatores de Transcrição/metabolismo , Ligação Competitiva/efeitos dos fármacos , Núcleo Celular/metabolismo , Proteínas de Ligação a DNA/biossíntese , Proteínas de Ligação a DNA/efeitos dos fármacos , Proteínas de Ligação a DNA/metabolismo , Proteínas de Ligação a DNA/fisiologia , Relação Dose-Resposta a Droga , Regulação Viral da Expressão Gênica/efeitos dos fármacos , HIV/efeitos dos fármacos , Humanos , Interferon-alfa/farmacologia , Interferon gama/farmacologia , Células Jurkat , NF-kappa B/antagonistas & inibidores , NF-kappa B/genética , NF-kappa B/metabolismo , Proteínas Nucleares/efeitos dos fármacos , Ligação Proteica/genética , Estrutura Terciária de Proteína , Fator de Transcrição STAT1 , Fator de Transcrição STAT2 , Transdução de Sinais/efeitos dos fármacos , Transativadores/metabolismo , Transativadores/fisiologia , Fator de Transcrição RelA , Fatores de Transcrição/efeitos dos fármacos , Transcrição Gênica/efeitos dos fármacos , Ativação Transcricional/efeitos dos fármacos , Fator de Necrose Tumoral alfa/farmacologiaRESUMO
The accessory protein, Vpr, is a virion-associated protein that is required for HIV-1 replication in macrophages and regulates viral gene expression in T cells. Vpr causes arrest of cell cycle progression at G2/M, presumably through its effect on cyclin B1.Cdc2 activity. Here, we show that the ability of Vpr to activate HIV transcription correlates with its ability to induce G2/M growth arrest, and this effect is mediated by the p300 transcriptional co-activator, which promotes cooperative interactions between the Rel A subunit of NF-kappaB and cyclin B1.Cdc2. Vpr cooperates with p300, which regulates NF-kappaB and the basal transcriptional machinery, to increase HIV gene expression. Similar effects are seen in the absence of Vpr with a kinase-deficient Cdc2, and overexpression of p300 increases levels of HIV Vpr+ replication. Taken together, these data suggest that p300, through its interactions with NF-kappaB, basal transcriptional components, and Cdks, is modulated by Vpr and regulates HIV replication. The regulation of p300 by Vpr provides a mechanism to enhance viral replication in proliferating cells after growth arrest by increasing viral transcription.
Assuntos
Produtos do Gene vpr/genética , HIV-1/genética , Proteínas Nucleares/fisiologia , Transativadores , Fatores de Transcrição/fisiologia , Proteína Quinase CDC2/fisiologia , Proteína de Ligação a CREB , Ciclo Celular , Regulação Viral da Expressão Gênica , Humanos , Células Jurkat , Transcrição Gênica , Replicação Viral , Produtos do Gene vpr do Vírus da Imunodeficiência HumanaAssuntos
Proteínas do Capsídeo , Capsídeo/farmacologia , Replicação do DNA , Proteínas de Ligação a DNA/farmacologia , DNA/biossíntese , Produtos do Gene gag/farmacologia , Inibidores da Síntese de Ácido Nucleico/farmacologia , Proteínas Virais , Animais , Transcriptase Reversa do HIV/metabolismo , HIV-1 , Humanos , Vírus da Imunodeficiência Felina/enzimologia , DNA Polimerase Dirigida por RNA/metabolismo , Proteína de Replicação A , Produtos do Gene gag do Vírus da Imunodeficiência HumanaRESUMO
Mammalian DNA polymerases alpha and epsilon, the Klenow fragment of Escherichia coli DNA polymerase I and HIV-1 reverse transcriptase (RT) were examined for their ability to incorporate components of an expanded genetic alphabet in different forms. Experiments were performed with templates containing 2'-deoxyxanthosine (dX) or 2'-deoxy-7-deazaxanthosine (c7dX), both able to adopt a hydrogen bonding acceptor-donor-acceptor pattern on a purine nucleus (puADA). Thus these heterocycles are able to form a non-standard nucleobase pair with 2,4-diaminopyrimidine (pyDAD) that fits the Watson-Crick geometry, but is joined by a non-standard hydrogen bonding pattern. HIV-1 RT incorporated d(pyDAD)TP opposite dX with a high efficiency that was largely independent of pH. Specific incorporation opposite c7dX was significantly lower and also independent of pH. Mammalian DNA polymerases alpha and epsilon from calf thymus and the Klenow fragment from E. coli DNA polymerase I failed to incorporate d(pyDAD)TP opposite c7dX.